pancreas
Research done in mice shows that the mouth-dwelling bacterium Porphyromonas gingivalis can travel from the mouth to the pancreas, resulting in lesions that lead to cancer.
This partnership aims to leverage Microba's advanced technology platform for measuring the human gut microbiome to discover novel biomarkers for pancreatic cancer detection.
The findings of a new study suggest that the microbial metabolite 3-IAA could help to treat PDAC.
The findings of a new research may help to develop improved diagnostic or treatment approaches for pancreatic cancer.
A gut microbial metabolite called trimethylamine N-oxide, or TMAO, could improve immunotherapy success in pancreatic cancer.
Certain fungi move from the gut to the pancreas, where they can trigger pancreatic cancer growth, according to a new study published in Nature.
The tumor microbiota could influence the pancreatic cancer survival, the 1st report to explore the effect of tumor bacteria on clinical outcomes claims.
The microbiota of a cancerous pancreas is different and larger than that of a non-cancerous pancreas, according to a study published in Cancer Discovery.
